Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.3109/10428194.2010.551570

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics